Cargando…

The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis

The effects of an intermittent fasting diet (IFD) in the general population are still controversial. In this study, we aimed to systematically evaluate the effectiveness of an IFD to reduce body mass index and glucose metabolism in the general population without diabetes mellitus. Cochrane, PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yongin, Hong, Namki, Kim, Kyung-won, Cho, Sung joon, Lee, Minyoung, Lee, Yeon-hee, Lee, Yong-ho, Kang, Eun Seok, Cha, Bong-Soo, Lee, Byung-Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832593/ https://www.ncbi.nlm.nih.gov/pubmed/31601019 http://dx.doi.org/10.3390/jcm8101645

Ejemplares similares

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
por: Lee, Minyoung, et al.
Publicado: (2020)

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
por: Cho, Yongin, et al.
Publicado: (2022)

Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
por: Han, Eugene, et al.
Publicado: (2020)

Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
por: Bae, Jaehyun, et al.
Publicado: (2022)

Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes
por: Yim, Jisook, et al.
Publicado: (2018)

Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2018)

Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
por: Kim, Hae Kyung, et al.
Publicado: (2022)

Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
por: Kim, Hae Kyung, et al.
Publicado: (2021)

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
por: Lee, Young Ki, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
por: Bae, Jaehyun, et al.
Publicado: (2020)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
por: Lee, Hyeok-Hee, et al.
Publicado: (2020)

Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
por: Lee, Inkuk, et al.
Publicado: (2020)

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
por: Kim, Youngsook, et al.
Publicado: (2022)

Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
por: Lee, Yong-ho, et al.
Publicado: (2018)

Body Mass Index Is Associated with Hypercholesterolemia following Thyroid Hormone Withdrawal in Thyroidectomized Patients
por: Shin, Dong Yeob, et al.
Publicado: (2014)

Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
por: Lee, Ji-Yeon, et al.
Publicado: (2021)

Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
por: Lee, Ji Young, et al.
Publicado: (2022)

The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
por: Choe, Eun Yeong, et al.
Publicado: (2014)

Association between dietary acid load and the risk of cardiovascular disease: nationwide surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2016)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2020)

Postprandial Triglyceride Is Associated with Fasting Triglyceride and HOMA-IR in Korean Subjects with Type 2 Diabetes
por: Lee, Seo Hee, et al.
Publicado: (2011)

The effects of the voglibose on non-alcoholic fatty liver disease in mice model
por: Bae, Jaehyun, et al.
Publicado: (2022)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
por: Huh, Ji Hye, et al.
Publicado: (2014)

Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes
por: Han, Eugene, et al.
Publicado: (2020)

Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
por: Cho, Yongin, et al.
Publicado: (2020)

The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA(1C) in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
por: Kim, So Ra, et al.
Publicado: (2017)

Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
por: Kim, So Ra, et al.
Publicado: (2017)

Replication of Interactions between Genome-Wide Genetic Variants and Body Mass Index in Fasting Glucose and Insulin Levels
por: Hong, Kyung-Won, et al.
Publicado: (2014)

Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis
por: Jang, Ji-Eun, et al.
Publicado: (2019)

Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2016)

The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
por: Kim, Wonjin, et al.
Publicado: (2014)

Age, Body Mass Index, and Spur Size Associated with Patients’ Symptoms in Plantar Fasciitis
por: Cho, Bong Wan, et al.
Publicado: (2022)

Mechanisms of Lifespan Regulation by Calorie Restriction and Intermittent Fasting in Model Organisms
por: Hwangbo, Dae-Sung, et al.
Publicado: (2020)

Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
por: Song, Young Mi, et al.
Publicado: (2016)

Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes
por: Lee, Eun Young, et al.
Publicado: (2016)

Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes
por: Song, Sun Ok, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8fo1b0e2ddv53d109alo7dbcik